Showing 1 - 2 results of 2 for search 'Luca Agnelli', query time: 0.01s Refine Results
  1. 1
    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).

    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). by Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer

    Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer by Elena Conca, Daniele Lorenzini, Daniele Lorenzini, Emanuela Minna, Luca Agnelli, Matteo Duca, Marco Gentili, Beatrice Bodini, Maggie Polignano, Mara Mantiero, Silvia Damian, Andrea Devecchi, Gianpaolo Dagrada, Rita Carminati, Alice Ardore, Francesca Barbetta, Nathalia Brito Da Chuna, Andrea Guerrizio, Adele Busico, Iolanda Capone, Alberta Piccolo, Elena Tamborini, Federica Perrone, Massimo Milione, Biagio Paolini, Andrea Vingiani, Andrea Vingiani, Francesco Raspagliesi, Francesco Raspagliesi, Filippo De Braud, Filippo De Braud, Giancarlo Pruneri, Giancarlo Pruneri

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: